| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/14/2013 | WO2013022972A1 Methods of treating progressive forms of multiple sclerosis |
| 02/14/2013 | WO2013022863A1 Cdr regions of monoclonal antibody that antagonize sphinogosine 1-phosphate and related methods |
| 02/14/2013 | WO2013022855A1 Antibodies with modified isoelectric points and immunofiltering |
| 02/14/2013 | WO2013022848A1 Anti-polyubiquitin antibodies and methods of use |
| 02/14/2013 | WO2013022782A1 Humanized universal light chain mice |
| 02/14/2013 | WO2013022599A1 Improved methods and compositions for modulation of olfml3 mediated angiogenesis |
| 02/14/2013 | WO2013022406A1 Angiopoietin-like 4 and its use in modulating cell leakiness |
| 02/14/2013 | WO2013022083A1 Novel anti-human ngf antibody |
| 02/14/2013 | WO2013021277A1 Recombinant ant-bovine iga antibody and uses thereof |
| 02/14/2013 | WO2013020995A1 New antibodies against phosphorylcholine |
| 02/14/2013 | WO2013020557A1 Method and antibodies for the identification of ubiquitinated proteins and sites of ubiquitination |
| 02/14/2013 | WO2013020266A1 Anti-mouse stk40 polyclonal antibody and preparation thereof |
| 02/14/2013 | WO2013003652A8 Multispecific stacked variable domain binding proteins |
| 02/14/2013 | WO2012175741A3 Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains |
| 02/14/2013 | WO2012143382A9 Gpr177 as target and marker in tumors |
| 02/14/2013 | WO2012128502A3 Composition for promoting vasculogenesis comprising pauf |
| 02/14/2013 | WO2012097238A3 Il-27 antagonists for treating inflammatory diseases |
| 02/14/2013 | WO2010017595A8 Variant domain antibodies |
| 02/14/2013 | US20130042331 Animal models and therapeutic molecules |
| 02/14/2013 | US20130041138 Antibodies that bind to psca proteins for diagnosis of cancer |
| 02/14/2013 | US20130041137 von Willebrand Factor (vWF) - Cleaving Protease |
| 02/14/2013 | US20130041136 Ligands that have binding specificity for egfr and/or vegf and methods of use therefor |
| 02/14/2013 | US20130041131 Glycosylated specificity exchangers |
| 02/14/2013 | US20130040882 Use of fibroblast growth factor fragments |
| 02/14/2013 | US20130040861 Novel methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries |
| 02/14/2013 | US20130040849 Method and kit for cancer diagnosis |
| 02/14/2013 | US20130040361 Novel antigen associated with the neovasculature of tumour metastases |
| 02/14/2013 | US20130040311 Monoclonal antibody against necrosis marker erp29 and use thereof |
| 02/14/2013 | US20130040310 Ulk1 compositions, inhibitors, screening and methods of use |
| 02/14/2013 | US20130039974 Anti-muc1 antibodies for cancer diagnostics |
| 02/14/2013 | US20130039931 Antibodies Against A Cancer-Associated Epitope of Variant HNRNPG and Uses Thereof |
| 02/14/2013 | US20130039927 Antigenic mimics of discontinuous epitopes of pathogen recognized by broadly neutralizing antibodies |
| 02/14/2013 | US20130039926 Human antibodies against rabies and uses thereof |
| 02/14/2013 | US20130039925 Alternative pathway specific antibodies for treating arthritis |
| 02/14/2013 | US20130039923 Anti-human interleukin-20 antibodies |
| 02/14/2013 | US20130039922 Antibodies that inhibit metalloproteins |
| 02/14/2013 | US20130039920 Specific binding proteins and uses thereof |
| 02/14/2013 | US20130039919 Novel plasminogen receptor, polypeptides and antibodies thereof |
| 02/14/2013 | US20130039918 Pharmaceutical Composition Using Connective-tissue Growth Factor |
| 02/14/2013 | US20130039917 Diagnostic and therapeutic target |
| 02/14/2013 | US20130039916 ENGINEERED ANTI-IL-23p19 ANTIBODIES |
| 02/14/2013 | US20130039915 Siglec 15 antibodies in treating bone loss-related disease |
| 02/14/2013 | US20130039914 Novel human genes relating to respiratory diseases and obesity |
| 02/14/2013 | US20130039913 Heterodimeric antibody fc-containing proteins and methods for production thereof |
| 02/14/2013 | US20130039907 Methods of treating hematological proliferative disorders by targeting epha3 expressed on aberrant vasculature in bone marrow |
| 02/14/2013 | US20130039851 Stabilizing Alkylglycoside Compositions and Methods Thereof |
| 02/14/2013 | US20130039849 Adenocarcinoma specific antibody sam-6, and uses thereof |
| 02/14/2013 | CA2844668A1 Methods and compositions for the treatment of autoimmune and inflammatory diseases |
| 02/14/2013 | CA2844662A1 Methods of treating progressive forms of multiple sclerosis |
| 02/14/2013 | CA2844435A1 Highly galactosylated antibodies |
| 02/14/2013 | CA2844070A1 Humanized universal light chain mice |
| 02/14/2013 | CA2843960A1 Antibodies binding to phosphorylcholine (pc) and/or pc conjugates |
| 02/14/2013 | CA2843921A1 New antibodies against phosphorylcholine |
| 02/14/2013 | CA2842971A1 Improved methods and compositions for modulation of olfml3 mediated angiogenesis |
| 02/14/2013 | CA2841181A1 Novel anti-human ngf antibody |
| 02/13/2013 | EP2557090A2 Amino acid sequences directed against GPCRs and polypeptides comprising the same for the treatment of GPCR-related diseases and disorders |
| 02/13/2013 | EP2556841A1 Method for inhibiting bone resorption |
| 02/13/2013 | EP2556747A2 Antibody producing non-human mammals. |
| 02/13/2013 | EP2556379A1 New diagnostic and therapeutic target |
| 02/13/2013 | EP2556148A2 Method for the generation of monoclonal antibodies derived from human b cells |
| 02/13/2013 | EP2556092A1 Fusion protein |
| 02/13/2013 | EP2556091A1 Antibody recognizing human leukemia inhibitory factor (lif) and use of anti-lif antibodies in the treatment of diseases associated with unwanted cell proliferation |
| 02/13/2013 | EP2556090A2 Soluble human st-2 antibodies and assays |
| 02/13/2013 | EP2556089A1 Self-assembling half-antibodies |
| 02/13/2013 | EP2556088A1 Plasma-derived immunoglobulin for use in the treatment and prevention of immune reconstitution inflammatory syndrome (iris) |
| 02/13/2013 | EP2555798A1 Methods and compositions for inhibiting hiv transmission |
| 02/13/2013 | EP2555797A1 Tnf- binding proteins |
| 02/13/2013 | EP2555794A1 COMPOSITIONS AND METHODS RELATED TO PROTEIN A (SpA) ANTIBODIES AS AN ENHANCER OF IMMUNE RESPONSE |
| 02/13/2013 | EP2555782A1 Compositions and methods for providing hematopoietic function without hla matching |
| 02/13/2013 | EP2555781A1 Compositions and methods for providing hematopoietic function |
| 02/13/2013 | EP2555614A1 Specific delivery of agrochemicals |
| 02/13/2013 | CN1953988B Peptides derived from human BPLP protein, polynucleotides coding for the peptides and antibodies directed against the peptides |
| 02/13/2013 | CN102933604A Anti-alpha 2 integrin antibodies and uses |
| 02/13/2013 | CN102933603A Methods for treating pancreatic cancer |
| 02/13/2013 | CN102933602A Antibodies to human GDF8 |
| 02/13/2013 | CN102933601A Amyloid-beta binding proteins |
| 02/13/2013 | CN102933600A Methods and composition for secretion of heterologous polypeptides |
| 02/13/2013 | CN102925413A Hybridoma producing anti-t-PSA monoclonal antibody, and preparation method of t-PSA detection kit |
| 02/13/2013 | CN102924601A Method for preparing ractopamine monoclonal antibodies |
| 02/13/2013 | CN102924600A Death receptor-5 agitated polyvalent antibody and application thereof in preparation of anti-tumor medicines |
| 02/13/2013 | CN102924599A Antibody, as well as application and preparation method thereof |
| 02/13/2013 | CN102924598A Anti-alphavbeta6 antibodies |
| 02/13/2013 | CN102924597A Stable and soluble antibodies inhibiting TNFa |
| 02/13/2013 | CN102924596A Anti-il-6 antibodies, compositions, methods and uses |
| 02/13/2013 | CN102924595A Nano antibody for hypoxia inducible factor to 1 alpha and coding sequence thereof |
| 02/13/2013 | CN102924594A Anti-tumor-protein-P63 monoclonal antibody and purpose thereof |
| 02/13/2013 | CN102924593A Application of chitosan to yolk fatty deposition and derosination technology |
| 02/13/2013 | CN102924584A Recombinant lubricin molecules and uses thereof |
| 02/13/2013 | CN102924577A Chicken high mobility group protein B1 (chHMGB1) antigen polypeptide and anti-chHMGB1 monoclonal antibody |
| 02/13/2013 | CN102921019A Delivering functional nucleic acids to mammalian cells via bacterially derived, intact minicells |
| 02/13/2013 | CN102921004A Immunoglobulin g (igg) concentrate depleted of anti-a and anti-b antibodies and of polyreactive iggs |
| 02/13/2013 | CN102319431B Monoclonal antibody for detecting and treating senile dementia |
| 02/13/2013 | CN102146116B Preparation and detection methods for specific antiserum of mogroside V |
| 02/13/2013 | CN101817881B Light-chain variable region and heavy-chain variable region of FMU-EPCAM-4F6 monoclonal antibody |
| 02/13/2013 | CN101802003B Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereof |
| 02/13/2013 | CN101693742B Anti-IGF-I receptor antibody |
| 02/13/2013 | CN101575374B Chicken Marek's virus antibody and preparation method thereof |
| 02/13/2013 | CN101505795B Composition for modulating the expression of cell adhesion molecules |
| 02/13/2013 | CN101341170B Antibodies against interleukin-22 binding protein and uses thereof |
| 02/13/2013 | CN101282992B 抗肌抑制素抗体 Anti-myostatin antibodies |